In this spotlight presentation, Mike Helme will give an overview of Cell Line Development (CLD) and its current therapeutics focus. He then moves on to the current challenges faced by many biopharma groups in the CLD market. After introducing the UP.SIGHT™, a multifaceted CLD device, he will explain how this platform addresses many of the challenges with its simple user-friendly interface offering the highest level of single-cell assurance. Some very positive data from an industrial partner with the UP.SIGHT™ will be introduced as well. Finally, Mike Helme will discuss how the CLD workflow has been automated within the C.STATION™ platform.
